We are live on ! Find out more

7 hedge funds and large institutions have $512K invested in PAVmed in 2018 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% less ownership

Funds ownership: 0.01%0% (-0%)

38% less capital invested

Capital invested by funds: $829K → $512K (-$317K)

50% less funds holding

Funds holding: 147 (-7)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

78% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 9

Holders
7
Holders Change
-7
Holders Change %
-50%
% of All Funds
0.16%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
1
Reduced
2
Closed
9
Calls
Puts
Net Calls
Net Calls Change

PAVM Hedge Fund Activity: Q4 2018 in Review

7 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in PAVmed (PAVM) for Q4 2018, worth a combined $512K — down 38% from $829K a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of PAVM and 2 opened new positions — a net loss of 7 holders — while 2 trimmed existing stakes and 1 added.

The largest buyer was Vanguard Group, adding an estimated $25.5K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $40K sold.

  • 7 institutional investors held PAVmed (PAVM) as of Q4 2018, down from 14 in Q3 2018.
  • Funds reported $512K of PAVmed stock for Q4 2018, down 38% quarter-over-quarter.
  • 2 funds opened new PAVmed positions in Q4 2018 and 9 closed out, a net change of -7 holders.
  • The largest PAVmed buyer in Q4 2018 was Vanguard Group, an estimated $25.5K added.
  • The largest PAVmed seller in Q4 2018 was Susquehanna International Group, an estimated $40K sold.

Based on aggregated 13F filings for Q4 2018.